UHS Universal Health Services, Inc.

$144.82▼ -1.21% Healthcare Other Last sync: just now Syncing
Key Metrics & Fundamentals
Market Cap
$8.77B
P/E Ratio
6.0
Div Yield
0.55%
52W Range
140.08 - 246.33
% vs 50 MA
-12.81%
% vs 200 MA
-26.39%
RSI-14
34.7
MACD Histogram
-0.4000
Beta (1Y vs SPY)
0.36
Free Cash Flow
$179.86M
Gross Rev
$4.50B
Gross Profit
$4.07B
EBITDA
$660.52M
COGS
$426.54M
Operating Exp
$3.57B
Operating Income
$502.86M
EBIT
$502.86M
Pretax Income
$469.12M
Net Income
$348.68M
EPS (Diluted)
5.65
Price & Volume History
Volume (M)
Financial Overview - Income Statement Quarterly
AI Analysis
Generated May 28, 3:42 PM
Company Overview

Universal Health Services, Inc. (UHS) is a prominent healthcare provider, operating acute care hospitals, behavioral health facilities, and ambulatory centers across the United States and the United Kingdom. It holds a significant competitive position, particularly in the behavioral health sector, catering to a broad spectrum of patient needs.

Bull Case
  • The P/E Ratio of 6.3 is notably low, suggesting the stock may be undervalued relative to its earnings compared to the broader market or sector peers.
  • UHS operates in essential healthcare services, particularly behavioral health, which typically exhibits resilient demand and can be less susceptible to economic downturns.
  • As a large, established player, UHS benefits from economies of scale, a diversified service offering, and a wide geographic footprint, providing a stable operational base.
  • The significant decline from its 52-week high and current oversold RSI could present a value opportunity for long-term investors if underlying fundamentals remain strong and market sentiment shifts.
Bear Case
  • The stock has experienced a substantial price decline of 38.8% from its 52-week high, indicating strong negative sentiment and a significant downtrend.
  • Technical indicators show considerable weakness, with the price trading well below both its 50-day and 200-day moving averages, confirming a bearish trend.
  • The RSI-14 of 28.6, while indicating oversold conditions, also reflects intense selling pressure and a lack of immediate buying interest, suggesting further downside risk or prolonged consolidation.
  • Healthcare providers like UHS face ongoing challenges related to labor shortages, rising wage costs, and potential changes in government reimbursement policies, which can impact profitability and margins.
Recent Performance

UHS has experienced significant downward pressure, with its price currently at $150.87, near its 52-week low of $150.18, and a daily decline of 2.2%. The stock is trading 11.3% below its 50-day moving average and 22.0% below its 200-day moving average, firmly establishing a strong bearish trend. The RSI-14 at 28.6 indicates the stock is deeply oversold, implying a potential for a technical bounce, but also reflecting the severity of the recent selling pressure and a lack of current buying momentum.

AI-generated analysis is for informational purposes only and does not constitute financial advice.

Not Financial Advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making any investment decisions. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙